News

PreMiEr researchers sampled countertops, drains and faucets in 41 North Carolina kitchens and found that every kitchen hosts its own distinct community of bacteria and fungi.

PreMiEr researchers Joseph L. Graves Jr. and Liesl Jeffers-Francis coauthored a study showing how quickly E. coli can develop resistance across multiple threats.

PreMiEr researcher Jeseth Delgado Vela and collaborators traced which bacteria carry antibiotic resistance genes as wastewater moves through treatment in North Carolina, Texas and California.

PreMiEr Affiliate Dr. Lawrence David co-authored a new study using wastewater analysis to identify community diet patterns across North Carolina, offering a low-cost alternative to traditional nutrition surveys.

A new PreMiEr study uses RNA sequencing to show that E. coli relies on very different genetic programs to resist phage attack and iron stress.

PreMiEr researchers at NC A&T show that phage T7, a virus that infects E. coli, can rapidly evolve resistance to ionic silver while becoming even better at killing bacteria.

A new PreMiEr manuscript finds that long-read DNA sequencing provides greater species-level detail for profiling fungal communities in indoor environments compared to short-read methods, offering practical guidance for indoor mycobiome researchers.

PreMiEr directors Claudia Gunsch and Joe Brown argue in Environmental Science and Technology that effective built environment microbial control requires moving beyond pathogen-killing toward microbiome-informed engineering that considers full community dynamics.

Dr. Stephen Fiore delivered a PreMiEr seminar on how structured team science and shared mental models can improve collaboration in complex interdisciplinary research environments, using PreMiEr integration meetings as a case study.

A new PreMiEr preprint finds that enhanced sink drain cleaning in hospitals reduces dangerous pathogens by driving ecological replacement rather than sterilization, with no effect on nearby countertop surfaces.

A new PreMiEr preprint introduces the concept of antipathobiotics, precision interventions that target pathogens in hospital environments while preserving beneficial microbes, offering an ecological alternative to broad-spectrum disinfection.

Nobel Prize winner Jennifer Doudna will speak at UNC on March 26th on how CRISPR is shaping the future of gene editing, human health, and global challenges.